Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20122
20132
20143
20172
20182
20192
20201
20217
20225
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting12
Completed9
Terminated5
Recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Pfizer4
Vertex Pharmaceuticals Incorporated3
CTI BioPharma2
Genzyme, a Sanofi Company2
Seagen Inc.2
Takeda2
Agios Pharmaceuticals, Inc.1
Amgen1
Ariad Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases31
Hemorrhagic Disorders9
Bone Marrow Diseases7
Genetic Diseases, Inborn7
Anemia6
Hemophilia A6
Lymphoma, Non-Hodgkin6
Anemia, Sickle Cell5
Blood Coagulation Disorders5
Coagulation Protein Disorders5

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.